Key result
Intravenous sodium nitroprusside achieved an 80% shock-reversal rate compared to 0% with saline in a rabbit model of massive pulmonary embolism with circulatory shock.
Why the study?
Does intravenous sodium nitroprusside improve hemodynamics and reverse circulatory shock in a rabbit model of massive pulmonary embolism?
RCT
randomly assigned
Does intravenous sodium nitroprusside improve hemodynamics and reverse circulatory shock in a rabbit model of massive pulmonary embolism?
Intravenous sodium nitroprusside partially reverses acute circulatory failure and improves hemodynamics in a rabbit model of massive pulmonary embolism, likely by reducing pulmonary vasospasm in nonembolic regions.
Answers are grounded in this paper and cite their sources.
Does not support clinical use in massive PE shock; leaves open human translation of nitroprusside.
We established a rabbit model of acute massive pulmonary embolism (PE) with associated circulatory shock using autologous blood clots. Rabbits were randomly assigned to a sham operation group (S group), model group (M group; equal volume of saline intravenously after shock), and sodium nitroprusside group (SNP group; sodium nitroprusside intravenously after shock). SNP treatment significantly decreased mean pulmonary arterial pressure and increased mean arterial pressure and arterial partial pressure of oxygen and resulted in a partial reversal of the acute circulatory failure. The shock-reversal rate was 0% in the M group and 80% in the SNP group. Moreover, pulmonary artery angiography and echocardiography examinations evidenced alleviated PE-induced changes after SNP therapy. 5-Hydroxytryptamine was significantly reduced in both PE and non-PE tissues, thromboxane A 2 level was significantly reduced in PE and tended to be lower in non-PE tissues, neutrophil accumulation was significantly reduced in both PE and non-PE tissues after SNP therapy. Our study demonstrated that pulmonary vasospasm in the nonembolic region might be a major pathologic factor leading to reduced left ventricular filling and circulatory shock after massive PE. Reduction of pulmonary vasospasm in the nonembolic area after SNP might serve as a major therapeutic mechanism involved in the observed beneficial effects of SNP in this model.
No takes yet. Share an insight, caveat, or question.
Yu et al. (2018) conducted an RCT in acute massive pulmonary embolism with associated circulatory shock. Sodium nitroprusside vs. Saline intravenously (model group) and sham operation was evaluated on shock-reversal rate. Intravenous sodium nitroprusside achieved an 80% shock-reversal rate compared to 0% with saline in a rabbit model of massive pulmonary embolism with circulatory shock.
Synapse has enriched 10 related papers. Consider them for comparative context: